122 related articles for article (PubMed ID: 29592817)
1. Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients.
Perner C; Perner F; Stubendorff B; Förster M; Witte OW; Heidel FH; Prell T; Grosskreutz J
J Neuroinflammation; 2018 Mar; 15(1):99. PubMed ID: 29592817
[TBL] [Abstract][Full Text] [Related]
2. Altered chemokine receptor profile on circulating leukocytes in human heart failure.
Athanassopoulos P; Vaessen LM; Balk AH; Weimar W; Sharma HS; Bogers AJ
Cell Biochem Biophys; 2006; 44(1):83-101. PubMed ID: 16456237
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia.
Katoh S; Fukushima K; Matsumoto N; Ehara N; Matsumoto K; Yamauchi A; Hirashima M
Int Arch Allergy Immunol; 2005 Jul; 137(3):229-35. PubMed ID: 15956791
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
5. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).
Aggarwal A; Agarwal S; Misra R
Clin Exp Immunol; 2007 Jun; 148(3):515-9. PubMed ID: 17374135
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients.
Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Matsumura Y; Kondo T; Yoshie O; Itoyama Y
J Neuroimmunol; 2006 Mar; 172(1-2):166-74. PubMed ID: 16427705
[TBL] [Abstract][Full Text] [Related]
7. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
Ng SK; Higashimori H; Tolman M; Yang Y
Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
[TBL] [Abstract][Full Text] [Related]
8. Expression of chemokine receptors in the different clinical forms of multiple sclerosis.
Martínez-Cáceres EM; Espejo C; Brieva L; Pericot I; Tintoré M; Sáez-Torres I; Montalban X
Mult Scler; 2002 Oct; 8(5):390-5. PubMed ID: 12356205
[TBL] [Abstract][Full Text] [Related]
9. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.
Proost P; Verpoest S; Van de Borne K; Schutyser E; Struyf S; Put W; Ronsse I; Grillet B; Opdenakker G; Van Damme J
J Leukoc Biol; 2004 May; 75(5):777-84. PubMed ID: 14996826
[TBL] [Abstract][Full Text] [Related]
10. Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood.
Mantovani S; Gordon R; Macmaw JK; Pfluger CM; Henderson RD; Noakes PG; McCombe PA; Woodruff TM
J Neuroimmunol; 2014 Nov; 276(1-2):213-8. PubMed ID: 25262158
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
12. Possible association between expression of chemokine receptor-2 (CCR2) and amyotrophic lateral sclerosis (ALS) patients of North India.
Gupta PK; Prabhakar S; Sharma NK; Anand A
PLoS One; 2012; 7(6):e38382. PubMed ID: 22685564
[TBL] [Abstract][Full Text] [Related]
13. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis.
Almad AA; Doreswamy A; Gross SK; Richard JP; Huo Y; Haughey N; Maragakis NJ
Glia; 2016 Jul; 64(7):1154-69. PubMed ID: 27083773
[TBL] [Abstract][Full Text] [Related]
14. Plasma Derived From Human Umbilical Cord Blood Modulates Mitogen-Induced Proliferation of Mononuclear Cells Isolated From the Peripheral Blood of ALS Patients.
Eve DJ; Ehrhart J; Zesiewicz T; Jahan I; Kuzmin-Nichols N; Sanberg CD; Gooch C; Sanberg PR; Garbuzova-Davis S
Cell Transplant; 2016; 25(5):963-71. PubMed ID: 26159164
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis.
Crisafulli SG; Brajkovic S; Cipolat Mis MS; Parente V; Corti S
Mol Neurobiol; 2018 Apr; 55(4):2789-2813. PubMed ID: 28455693
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse.
Mahad DJ; Lawry J; Howell SJ; Woodroofe MN
Mult Scler; 2003 Mar; 9(2):189-98. PubMed ID: 12708814
[TBL] [Abstract][Full Text] [Related]
17. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig.
Piali L; Weber C; LaRosa G; Mackay CR; Springer TA; Clark-Lewis I; Moser B
Eur J Immunol; 1998 Mar; 28(3):961-72. PubMed ID: 9541591
[TBL] [Abstract][Full Text] [Related]
18. Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations.
Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir M; Feki M; Hamzaoui K
J Autoimmun; 2004 Nov; 23(3):267-73. PubMed ID: 15501397
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an early innate immune response in the motor cortex of ALS.
Jara JH; Genç B; Stanford MJ; Pytel P; Roos RP; Weintraub S; Mesulam MM; Bigio EH; Miller RJ; Özdinler PH
J Neuroinflammation; 2017 Jun; 14(1):129. PubMed ID: 28651542
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis.
Rashid Chehreh Bargh S; Tafakhori A; Masoumi F; Rahmani F; Ahmadi M; Namdar A; Azimi M; Tavasolian P; Habibi S; Zamani B; Maserrat M; Sadr M; Noorbakhsh F; Rezaei N
Ir J Med Sci; 2018 Nov; 187(4):1065-1071. PubMed ID: 29574662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
